Neuronetics (STIM)

NeuroStar works by delivering targeted magnetic pulses to areas of the brain associated with mood regulation. The system is designed for use in outpatient clinical settings, giving psychiatrists and other trained providers a device-based treatment option that can be integrated into a broader mental health care program. Neuronetics supports the platform with equipment sales, treatment-session consumables, practice-development services, training, and patient-awareness initiatives.

The company operates through medical device and clinic services activities. Its device business is centered on expanding adoption of NeuroStar among physician practices and treatment centers, while the clinic services segment gives Neuronetics more direct exposure to patient care delivery and the economics of TMS treatment. As a listed medical technology company, Neuronetics sits at the intersection of mental health care, neuromodulation, and outpatient specialty medicine. Its growth depends on physician adoption, reimbursement coverage, patient demand, clinical evidence, and its ability to differentiate NeuroStar in a competitive market for depression therapies.